The challenges of chronic obstructive pulmonary diseases (COPD)--a perspective.

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory disease, primarily caused by cigarette smoke, which will soon become the third leading cause of death globally. Despite the importance of the problem, our real understanding of the biological underpinnings of COPD remains incomplete. Consequently, our first-line therapies, while helpful, are not yet as effective as they need to be. In this review, we will focus on these challenges and more, including the role of impaired tissue repair and adaptive immunity in disease pathogenesis, determining who may be at risk, describing COPD phenotypes and potential biomarkers. New ideas for chronic disease management and prevention of exacerbations will also be discussed. While much remains to be accomplished, meeting these challenges will bring rewards because what we learn will have implications for the understanding and treatment of chronic inflammatory diseases beyond COPD.

• Authors: R William Vandivier, Norbert F Voelkel
• Journal: COPD (COPD) Vol. 2 Issue 1 Pg. 177-84 (Mar 2005) ISSN: 1541-2555 [Print] England
• PMID: 17136979 (Publication Type: Journal Article, Review)

Topics

• Humans
• Pulmonary Disease, Chronic Obstructive (diagnosis, etiology, therapy)
• Risk Factors